COVID 19 Vaccine Name List | Coronavirus Vaccines List Worldwide 2022 – National regulatory authorities have granted emergency use authorizations for thirty COVID-19 vaccines. Nine vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO):
- Pfizer–BioNTech
- Oxford–AstraZeneca
- Sinopharm BIBP
- Moderna, Janssen
- CoronaVac
- Covaxin
- Novavax,
- Medicago.
Five others are under assessment by the WHO: Sputnik V, Sinopharm WIBP, Convidecia, Sanofi–GSK and SCB-2019. Specific versions of five vaccines have been authorised by the European Medicines Agency (EMA): Pfizer–BioNTech, Janssen, Novavax, Moderna and Oxford–AstraZeneca. Specific versions of another four vaccines are under evaluation by the EMA: Sputnik V, CoronaVac, Sanofi–GSK and Valneva. Delhi New Corona Guidelines 2022 : School, Colleges, Hospital, Hotels Pdf
COVID 19 Vaccine Name List | Coronavirus Vaccines List Worldwide 2022
| Name | Vaccine Type | Primary Developers | Country of Origin |
| Comirnaty (BNT162b2) | mRNA-based vaccine | Pfizer, BioNTech, Fosun Pharma | Multinational |
| Moderna COVID‑19 Vaccine (mRNA-1273) | mRNA-based vaccine | Moderna, BARDA, NIAID | US |
| COVID-19 Vaccine AstraZeneca (AZD1222); also known as Vaxzevria and Covishield | Adenovirus vaccine | BARDA, OWS | UK |
| Sputnik V | Recombinant adenovirus vaccine (rAd26 and rAd5) | Gamaleya Research Institute, Acellena Contract Drug Research and Development | Russia |
| Sputnik Light | Recombinant adenovirus vaccine (rAd26) | Gamaleya Research Institute, Acellena Contract Drug Research and Development | Russia |
| COVID-19 Vaccine Janssen (JNJ-78436735; Ad26.COV2.S) | Non-replicating viral vector | Janssen Vaccines (Johnson & Johnson) | The Netherlands, US |
| CoronaVac | Inactivated vaccine (formalin with alum adjuvant) | Sinovac | China |
| BBIBP-CorV | Inactivated vaccine | Beijing Institute of Biological Products;Â China National Pharmaceutical Group (Sinopharm) | China |
| EpiVacCorona | Peptide vaccine | Federal Budgetary Research Institution State Research Center of Virology and Biotechnology | Russia |
| Convidicea (Ad5-nCoV) | Recombinant vaccine (adenovirus type 5 vector) | CanSino Biologics | China |
| Covaxin (BBV152) | Inactivated vaccine | Bharat Biotech, ICMR; Ocugen | India |
| WIBP-CorV | Inactivated vaccine | Wuhan Institute of Biological Products;Â China National Pharmaceutical Group (Sinopharm) | China |
| CoviVac | Inactivated vaccine | Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products | Russia |
| ZF2001 | Recombinant vaccine | Anhui Zhifei Longcom Biopharmaceutical, Institute of Microbiology of the Chinese Academy of Sciences | China, Uzbekistan |
| QazVac (QazCovid-in) | Inactivated vaccine | Research Institute for Biological Safety Problems | Kazakhstan |
